Apnimed Stock
Apnimed is focused on developing oral pharmacologic therapies for obstructive sleep apnea (OSA) and related sleep disorders. Their investigational oral therapy, AD109, aims to simplify treatment and improve oxygenation for individuals with OSA.
Sign up for SecondMarket® to view the market and buy or sell Apnimed Stock
Buy + SellApnimed Funding
Sign up to gain insights into Apnimed funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series D | Apr 23, 2025 | 16.50M | ||
| Series C | Dec 22, 2022 | 79.75M | ||
| Series C | Nov 01, 2022 | 25.00M | ||
| Series C | Apr 28, 2022 | 37.50M | ||
| Series B | Mar 12, 2021 | 25.00M | ||
| Series B | Mar 31, 2020 | 15.00M | ||
| Series A | Aug 07, 2019 | 6.00M | ||
| Series A | Jan 10, 2019 | 10.00M | ||
| Series A | Aug 09, 2018 | 4.50M | ||
| Series A | Jun 25, 2018 | 5.08M |
See Apnimed Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Apnimed Stock Valuation + Share Prices
View real-time Tape D® data on Apnimed stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Apnimed Management Team
-
CEO
Lawrence G. Miller
-
Chief Business Officer
Barry Wohl
-
Chief Medical Officer
Ron Farkas
-
Chief Scientific Officer
Luigi Taranto Montemurro
-
COO
Dennis P. Molnar
-
Chief Commercial Officer
Graham Goodrich
-
Chief Financial Officer
Ramzi Benamar
Learn More About Apnimed Stock
Buy Apnimed Stock
01Apnimed stock does not trade on public stock exchanges. Apnimed stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Apnimed stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Apnimed Stock
02Apnimed Stock does not trade on public stock exchanges. In order to sell Apnimed shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Apnimed Stock Price
03Apnimed does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Apnimed share price and other valuable private market data.
Read more about secondary market private company stock prices:
Apnimed Stock Ticker Symbol
04There is no ticker symbol for Apnimed stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Apnimed Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Apnimed stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Apnimed Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Apnimed stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Apnimed Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Apnimed IPO
08Apnimed is a private company and has not had an IPO. There is currently no Apnimed IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Apnimed IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Apnimed Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
